19.32
Tango Therapeutics Inc (TNGX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
100.00%
-
|
53.81 | 3.181 | 5.392 | 4.117 |
|
|
5.35%
41.86
|
39.74 | 44.15 | 47.92 | 45.03 |
| Benefits Costs and Expenses |
2.29%
38.80
|
37.94 | 42.00 | 45.23 | 41.74 |
| Costs And Expenses |
2.29%
38.80
|
37.94 | 42.00 | 45.23 | 41.74 |
| Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
| Operating Income/Loss |
397.50%
-41.86
|
14.07 | -40.97 | -42.53 | -40.91 |
| Net Interest Income/Expense |
53.14%
1.68
|
1.097 | 1.239 | 1.614 | 1.813 |
| Nonoperating Income/Loss |
69.81%
3.06
|
1.802 | 2.149 | 2.688 | 3.289 |
| Income/Loss From Continuing Operations Before Tax |
344.45%
-38.80
|
15.87 | -38.82 | -39.84 | -37.62 |
| Income Tax Expense/Benefit |
450.00%
-0.055
|
-0.01 | 0.035 | 0.034 | 0.049 |
| Income/Loss From Continuing Operations After Tax |
343.95%
-38.75
|
15.88 | -38.85 | -39.88 | -37.67 |
|
|
343.95%
-38.75
|
15.88 | -38.85 | -39.88 | -37.67 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
95.13%
5.4045
|
110.97 | 110.54 | 110.30 | 0.2367 |
| Diluted Average Shares |
95.41%
5.4045
|
117.78 | 110.54 | 110.30 | 0.2367 |
| Basic Earnings Per Share |
314.29%
-0.30
|
0.14 | -0.35 | -0.36 | -0.34 |
| Diluted Earnings Per Share |
330.77%
-0.30
|
0.13 | -0.35 | -0.36 | -0.34 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):